Evidence map›Paper›PMID 42524343›Full record

ReviewJournal of Cancer2026

tsRNA's Biological Function and its Potential Application in Disease Diagnosis and Prognosis.

Congcong Tang, Qi Tang, Siyuan Tang, Faqing Tang

Abstract readReview
In one paragraph

Review in Journal of Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Congcong TangHunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital, and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Qi TangHunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital, and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Siyuan TangXiangya School of Nursing, Central South University, Changsha, China.
Faqing TangHunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital, and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Under physiological conditions, tsRNAs regulate mRNA transcription, reverse transcription, and protein translation to mediate cell apoptosis, cell cycle, and epigenetic regulation. Pathogenic tsRNAs are disease-specific or disease-related tsRNAs that are highly express in various diseases and may serve as diagnostic or potential diagnostic biomarkers. Specifically expressed tsRNAs in tumors were screened and obtained from the tumors. Although the mechanisms by which these oncogenic tsRNAs contribute to tumor development remain unclear, they have been shown to be applicable to tumor diagnosis and therapeutic prognosis. This article briefly summarizes pathogenic tsRNAs involved in various diseases and their biological functions. Oncogenic tsRNAs in tumors and their clinical applications have been elaborated upon. The molecular mechanisms of pathological tsRNAs in both general diseases and tumors need to be further investigated in future.

Indexed as

biomarkernon-tumor diseaseregulatory mechanismtsRNAtumor

Identifiers

PMID42524343
PMCPMC13410615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.